Evidence map›Paper›PMID 33554302›Full record

ArticleBiotechnology letters2021

Performance evaluation of a novel conceptual bioprocess for clinically-required mass production of hematopoietic cells.

Leila Shafiei Kaleybar, Ali Baradar Khoshfetrat, Reza Rahbarghazi, Hojjatollah Nozad Charoudeh

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Leila Shafiei KaleybarChemical Engineering Faculty, Sahand University of Technology, 51335-1996, Tabriz, Iran.
Ali Baradar KhoshfetratChemical Engineering Faculty, Sahand University of Technology, 51335-1996, Tabriz, Iran. Khoshfetrat@sut.ac.ir.ORCID http://orcid.org/0000-0001-5939-5201
Reza RahbarghaziStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hojjatollah Nozad CharoudehStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sahand University of Technology · IRTabriz University of Medical Sciences · IR

Funding

Iran National Science Foundation 96000408
6 · The paper itself

Abstract

objectiveThe novel engineered bioprocess, which was designed and modeled to provide the clinically relevant cell numbers for different therapies in our previous work (Kaleybar et al. Food Bioprod Process 122:254-268, https://doi.org/10.1016/j.fbp.2020.04.012 , 2020), was evaluated by using U937 as hematopoietic model cells.

resultsThe culture system showed a 30-fold expansion of U937 cells in one-step during a 10-day culture period. The cell growth profile, the substrate and oxygen consumptions, and byproduct formations were all in agreement with the model predications during 7 days. The cell proliferation decrease after 7 days was attributed to optional oxygen limiting condition in the last days of culture. The bioreactor culture system revealed also a slight enhancement of lactate dehydrogenase (LDH) production as compared to the 2D conventional culture system, indicating the low impact of shear stress on cellular damage in the dynamic system.

conclusionsThe results demonstrated that the conceptual bioprocess for suspended stem cell production has a great potential in practice although additional experiments are required to improve the system.

Indexed as

Batch Cell Culture TechniquesBioreactorsCell ProliferationCell SurvivalCulture MediaHematopoietic Stem CellsHumansModels, BiologicalOxygenU937 CellsCulture MediaOxygenConceptual bioprocessMass productionSequencing batch aerationStirred tank bioreactorSuspended stem cell

Identifiers

PMID33554302
OpenAlexW3129082532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.